α-NETA reduced the incidence of EAE by day 24 by nearly 25%, although this did not reach statistical significance ( Table 4 ).
← all excerpts
A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.
1
—
—
α-NETA reduced the incidence of EAE by day 24 by nearly 25%, although this did not reach statistical significance ( Table 4 ).